{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T14:48:26Z","timestamp":1790606906834,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","giejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastrointestinal Endoscopy"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.gie.2024.04.2904","type":"journal-article","created":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T01:45:05Z","timestamp":1714355105000},"page":"896-904","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Recellularization via electroporation therapy of the duodenum combined with glucagon-like peptide-1 receptor agonist to replace insulin therapy in patients with type 2 diabetes: 12-month results of a first-in-human study"],"prefix":"10.1016","volume":"100","author":[{"given":"Celine B.E.","family":"Busch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Meiring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1351-0267","authenticated-orcid":false,"given":"Annieke C.G.","family":"van Baar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frits","family":"Holleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Nieuwdorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques J.G.H.M.","family":"Bergman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gie.2024.04.2904_bib1","unstructured":"World Health Organization. Diabetes. Available at: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/diabetes. Accessed March 23, 2023."},{"key":"10.1016\/j.gie.2024.04.2904_bib2","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S0140-6736(13)62154-6","article-title":"Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future","volume":"383","author":"Kahn","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.gie.2024.04.2904_bib3","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00125-014-3460-0","article-title":"Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes","volume":"58","author":"Inzucchi","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/j.gie.2024.04.2904_bib4","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/dom.12412","article-title":"Glucose-lowering with exogenous insulin monotherapy in type 2 diabetes: dose association with all-cause mortality, cardiovascular events and cancer","volume":"17","author":"Holden","year":"2015","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.gie.2024.04.2904_bib5","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/j.1463-1326.2006.00686.x","article-title":"Insulin-associated weight gain in diabetes\u2014causes, effects and coping strategies","volume":"9","author":"Russell-Jones","year":"2007","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.gie.2024.04.2904_bib6","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jdiacomp.2014.11.018","article-title":"Benefits of timely basal insulin control in patients with type 2 diabetes","volume":"29","author":"Lovre","year":"2015","journal-title":"J\u00a0Diabetes Complications"},{"key":"10.1016\/j.gie.2024.04.2904_bib7","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1038\/s42255-021-00458-9","article-title":"Diet-induced alteration of intestinal stem cell function underlies obesity and prediabetes in mice","volume":"3","author":"Aliluev","year":"2021","journal-title":"Nat Metab"},{"key":"10.1016\/j.gie.2024.04.2904_bib8","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/nutrit\/nuy064","article-title":"Intestinal plasticity in response to nutrition and gastrointestinal surgery","volume":"77","author":"Le Gall","year":"2019","journal-title":"Nutr Rev"},{"key":"10.1016\/j.gie.2024.04.2904_bib9","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.peptides.2017.12.010","article-title":"Intestinal peptide changes after bariatric and minimally invasive surgery: relation to diabetes remission","volume":"100","author":"Castagneto","year":"2018","journal-title":"Peptides"},{"key":"10.1016\/j.gie.2024.04.2904_bib10","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.jpeds.2015.08.020","article-title":"Insulin sensitivity and beta-cell function improve after gastric bypass in severely obese adolescents","volume":"167","author":"Inge","year":"2015","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.gie.2024.04.2904_bib11","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.gie.2020.12.021","article-title":"Duodenal mucosal resurfacing combined with glucagon-like peptide-1 receptor agonism to discontinue insulin in type 2 diabetes: a feasibility study","volume":"94","author":"van Baar","year":"2021","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.gie.2024.04.2904_bib12","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/01.sla.0000224726.61448.1b","article-title":"The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes","volume":"244","author":"Rubino","year":"2006","journal-title":"Ann Surg"},{"key":"10.1016\/j.gie.2024.04.2904_bib13","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1136\/gutjnl-2020-323608","article-title":"Safety and efficacy of hydrothermal duodenal mucosal resurfacing in patients with type 2 diabetes: the randomised, double-blind, sham-controlled, multicentre REVITA-2 feasibility trial","volume":"71","author":"Mingrone","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.gie.2024.04.2904_bib14","doi-asserted-by":"crossref","first-page":"107871","DOI":"10.1016\/j.bioelechem.2021.107871","article-title":"Cell death due to electroporation\u2014a review","volume":"141","author":"Napotnik","year":"2021","journal-title":"Bioelectrochemistry"},{"key":"10.1016\/j.gie.2024.04.2904_bib15","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1080\/14779072.2018.1459185","article-title":"Irreversible electroporation for the treatment of cardiac arrhythmias","volume":"16","author":"Sugrue","year":"2018","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.gie.2024.04.2904_bib16","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1053\/j.seminoncol.2021.02.004","article-title":"Irreversible electroporation of locally advanced pancreatic cancer","volume":"48","author":"Kwon","year":"2021","journal-title":"Semin Oncol"},{"key":"10.1016\/j.gie.2024.04.2904_bib17","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1148\/radiol.2020192190","article-title":"High-voltage electrical pulses in oncology: irreversible electroporation, electrochemotherapy, gene electrotransfer, electrofusion, and electroimmunotherapy","volume":"295","author":"Geboers","year":"2020","journal-title":"Radiology"},{"key":"10.1016\/j.gie.2024.04.2904_bib18","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1111\/dom.14785","article-title":"C-peptide determination in the diagnosis of type of diabetes and its management: a clinical perspective","volume":"24","author":"Maddaloni","year":"2022","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.gie.2024.04.2904_bib19","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1477-7525-5-57","article-title":"The Diabetes Treatment Satisfaction Questionnaire change version (DTSQc) evaluated in insulin glargine trials shows greater responsiveness to improvements than the original DTSQ","volume":"5","author":"Bradley","year":"2007","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.gie.2024.04.2904_bib20","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.gie.2017.07.018","article-title":"Guidelines for sedation and anesthesia in GI endoscopy","volume":"87","author":"Early","year":"2018","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.gie.2024.04.2904_bib21","series-title":"Ozempic","year":"2022"},{"key":"10.1016\/j.gie.2024.04.2904_bib22","doi-asserted-by":"crossref","first-page":"530","DOI":"10.2337\/diacare.22.3.530","article-title":"Diabetes treatment satisfaction questionnaire. Change version for use alongside status version provides appropriate solution where ceiling effects occur","volume":"22","author":"Bradley","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.gie.2024.04.2904_bib23","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.gie.2024.04.2904_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/edm2.51","article-title":"Real-world GLP-1 RA therapy in type 2 diabetes: a long-term effectiveness observational study","volume":"2","author":"Tofe","year":"2019","journal-title":"Endocrinol Diabetes Metab"},{"key":"10.1016\/j.gie.2024.04.2904_bib25","unstructured":"Farmacotherapeutisch kompas. Semaglutide. Available at: www.farmacotherapeutischkompas.nl\/bladeren\/preparaatteksten\/s\/semaglutide. Accessed October 20, 2023."},{"key":"10.1016\/j.gie.2024.04.2904_bib26","unstructured":"European Medicines Agency (EMA). Semaglutide. Available at: www.ema.europa.eu\/en\/medicines\/human\/EPAR\/ozempic. Accessed October 20, 2023."},{"key":"10.1016\/j.gie.2024.04.2904_bib27","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1001\/jama.2021.23619","article-title":"Effect of weekly subcutaneous semaglutide vs daily liraglutide on body weight in adults with overweight or obesity without diabetes: the STEP 8 randomized clinical trial","volume":"327","author":"Rubino","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.gie.2024.04.2904_bib28","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/qjmed\/hcq112","article-title":"Exenatide therapy in insulin-treated type 2 diabetes and obesity","volume":"103","author":"Nayak","year":"2010","journal-title":"QJM"},{"key":"10.1016\/j.gie.2024.04.2904_bib29","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.2337\/dc12-2454","article-title":"Adding once-daily lixisenatide for type 2 diabetes inadequately controlled by established basal insulin: a 24-week, randomized, placebo-controlled comparison (GetGoal-L)","volume":"36","author":"Riddle","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.gie.2024.04.2904_bib30","doi-asserted-by":"crossref","first-page":"364","DOI":"10.4093\/dmj.2012.36.5.364","article-title":"Effects of a 6-month exenatide therapy on HbA1c and weight in Korean patients with type 2 diabetes: a retrospective cohort study","volume":"36","author":"Shin","year":"2012","journal-title":"Diabetes Metab J"},{"key":"10.1016\/j.gie.2024.04.2904_bib31","first-page":"523","article-title":"A\u00a0prospective study of concomitant GLP-1 analogue and insulin use in type 2 diabetes in clinical practice","volume":"72","author":"van Velsen","year":"2014","journal-title":"Neth J Med"}],"container-title":["Gastrointestinal Endoscopy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016510724031638?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016510724031638?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:34:00Z","timestamp":1731544440000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016510724031638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S0016510724031638"],"URL":"https:\/\/doi.org\/10.1016\/j.gie.2024.04.2904","relation":{},"ISSN":["0016-5107"],"issn-type":[{"value":"0016-5107","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recellularization via electroporation therapy of the duodenum combined with glucagon-like peptide-1 receptor agonist to replace insulin therapy in patients with type 2 diabetes: 12-month results of a first-in-human study","name":"articletitle","label":"Article Title"},{"value":"Gastrointestinal Endoscopy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gie.2024.04.2904","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American Society for Gastrointestinal Endoscopy","name":"copyright","label":"Copyright"}]}}